PORTLAND, Maine, April 10, 2012 /PRNewswire/ -- Putney, Inc., a rapidly growing pet pharmaceutical company focused on the development and sale of generic prescription medicines for pets, announced

Shire Pharmaceuticals has settled a crucial patent case with US generics company Barr Laboratories regarding its ADHD drug Adderall XR.

Shire and Barr Laboratories have come to an agreement to settle all pending litigation over the latter's proposed generic version of Shire's Adderall XR, an extended release treatment for attention deficit hyperactivity disorder.

U.S. drug regulators may soon permit the over-the-counter sale of a morning-after birth control pill.

By Kathleen Kerr, Newsday, Melville, N.Y. Aug. 1--In a surprise move, the Food and Drug Administration said yesterday it could approve over-the-counter sales of a controversial emergency contraceptive to women 18 and older in a few weeks.